Cheyenne, WY -- (SBWIRE) -- 10/09/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Northern Oil & Gas, Inc. (NYSEMKT: NOG), Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Westport Innovations Inc. (USA) (NASDAQ:WPRT), Affymetrix, Inc. (NASDAQ:AFFX)
Northern Oil & Gas, Inc. (NYSEMKT: NOG) managed to keep its gain at 0.67% on above-normal volume of 1.25M shares. The stock settled at $15.04 after floating in a range of $14.54 to $15.34. Its latest price has reached market capitalization of $959.68 million. Its 52-week range has been $11.80 to $17.88. Northern Oil and Gas, Inc., an independent energy company, engages in the acquisition, exploration, development, and production of crude oil and natural gas properties in North Dakota and Montana.
For How Long NOG will fight for Profitability? Read This Trend Analysis report
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) traded down on a volume of 1.25 million, higher than its standard daily volume. Shares have gained 0.67% to $15.04. Over the last twelve months, the stock has lost-7.53% and faced a worst price of $11.80. Northern Oil and Gas, Inc. is an independent energy company. The Company is engaged in the acquisition, exploration, development and production of oil and natural gas properties, primarily in the Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana.
For How Long INFI’s Gloss will Attract Investors? Find out via this report
Westport Innovations Inc. (USA) (NASDAQ:WPRT) settled -1.96% lower at $24.48 on above-normal volume of 1.25M shares during the last trading day. The stock has its 12-month high at $35.40 and 52-week low price was $23.01. It traded in a range of $24.20 to $25 during the last trading day. nfinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to patients for diseases with significant unmet need.
Why Should Investors Buy WPRT After the Recent Fall? Just Go Here and Find Out
In the last trading session, Affymetrix, Inc. (NASDAQ:AFFX) showed no change on low volume, trading at a volume of 1.25M shares versus its average daily volume of 1.31 million shares. At $6.38, the stock has attained market capitalization of $456.63 million. Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix has developed its GeneChip system and related microarray technology as a platform for acquiring, analyzing and managing genetic information.
Can AFFX Show a Strong Recovery? Find out in This Research Report
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)